Table 1 Baseline clinical and demographic data of patients included in the study.
Variable | (n = 80) |
|---|---|
Age (years). Median (IQR) | 41.5 (33.6–47.3) |
Disease duration (years). Median (IQR) | 9.5 (4.4–16.3) |
Sex (Male/female) | 19/61 |
EDSS score. Median (IQR) | 1.5 (1.5–2.5) |
MSSS score. Median (IQR) | 2.2 (1.3–4.2) |
N. of total previous relapses. Median (IQR) | 4 (2–6) |
N. of patients with relapses in the previous year (Yes/no) | 50/30 |
N. of relapses in the previous year. Median (IQR) | 1 (0–1) |
Time from the last relapse (months). Median (IQR) | 6.0 (3.0–9.2) |
N. of patients with relapses in the previous 3 months (Yes/no) | 16/64 |
N. of T2 lesions. Median (IQR) | 19 (12–27) |
N. of patients with Gd+ enhanced lesions (Yes/no) | 24/56 |
N. of Gd+ enhanced lesions. Median (IQR) | 0 (0–1) |
Previous treatments (Naïve/Previously treated) | 25/55 |
Previous treatments (FL/SL) | 45/10 |
Washout period (months). Median (IQR) | 2 (2–4) |
